Baird Upgrades Edwards Lifesciences (EW) to Outperform

November 5, 2026 7:41 AM EST Send to a Friend
Baird analyst David Rescott upgraded Edwards Lifesciences (NYSE: EW) from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login